Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse
about
Acute overactive endocannabinoid signaling induces glucose intolerance, hepatic steatosis, and novel cannabinoid receptor 1 responsive genesHigh-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouseCentral role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndromeNew role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditureThe blind men 'see' the elephant-the many faces of fatty liver diseaseNegative regulation of cytokine signaling and immune responses by SOCS proteinsInsulin receptor signaling in normal and insulin-resistant statesMechanisms of chronic JAK-STAT3-SOCS3 signaling in obesityLipocalin 13 regulation of glucose and lipid metabolism in obesityPathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitisMiR-155 Enhances Insulin Sensitivity by Coordinated Regulation of Multiple Genes in MiceMyeloid cell-restricted insulin receptor deficiency protects against obesity-induced inflammation and systemic insulin resistanceNon-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1Molecular mechanisms of insulin resistance in chronic hepatitis CDeletion of skeletal muscle SOCS3 prevents insulin resistance in obesityMacrophage function in obesity-induced inflammation and insulin resistance.Paget disease of bone-associated UBA domain mutations of SQSTM1 exert distinct effects on protein structure and functionMetabolic network topology reveals transcriptional regulatory signatures of type 2 diabetes.Dysregulation of sterol regulatory element binding protein-1c in livers of morbidly obese women is associated with altered suppressor of cytokine signaling-3 and signal transducer and activator of transcription-1 signaling.Expression and regulation of facilitative glucose transporters in equine insulin-sensitive tissue: from physiology to pathology.Metabolic syndrome: is equine disease comparable to what we know in humans?Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolismNon-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.SOCS1, a Negative Regulator of Cytokine Signals and TLR Responses, in Human Liver Diseases.Interleukin-6 mediates hepatic hypersecretion of apolipoprotein B.Common polymorphisms in SOCS3 are not associated with body weight, insulin sensitivity or lipid profile in normal female twinsCardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver diseaseSuboptimal maternal nutrition, during early fetal liver development, promotes lipid accumulation in the liver of obese offspring.Regulation of insulin and leptin signaling by muscle suppressor of cytokine signaling 3 (SOCS3).Alteration of JNK-1 signaling in skeletal muscle fails to affect glucose homeostasis and obesity-associated insulin resistance in miceAbrogation of growth hormone secretion rescues fatty liver in mice with hepatocyte-specific deletion of JAK2.Nutrigenomics of high fat diet induced obesity in mice suggests relationships between susceptibility to fatty liver disease and the proteasome.Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents β cell failure in rodent models of type 2 diabetes.Deletion of interleukin-6 improves pyruvate tolerance without altering hepatic insulin signaling in the leptin receptor-deficient mouse.The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients.Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice.SOCS-1 deficiency does not prevent diet-induced insulin resistance.Temporal relationship between diet-induced steatosis and onset of insulin/leptin resistance in male Wistar rats.Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR ratsDepletion of suppressor of cytokine signaling-1a causes hepatic steatosis and insulin resistance in zebrafish.
P2860
Q21090979-9B88781C-B7C3-405E-B438-01A85E49B479Q21136177-F6A7E46E-5719-45CA-B51B-E07D7F65DB3EQ24648112-606F656F-654E-43C0-8E0E-41417DFF0EC0Q24652521-40665CAA-DAB0-4F6B-B4A1-A4F12C1B886DQ24654991-490B80FD-767D-465A-92F9-985E78F230BDQ24816896-14AC0DE6-B327-4CB2-8130-8F988748D6A9Q26823171-CCF51E44-D41E-4220-A9E8-B96191F7F0A6Q26850181-A92DC27C-8405-4970-8F39-E1F9D512CAE7Q26996675-8D79653D-9D2A-4606-B34D-6459CF8623B7Q27022707-38589766-E18F-4E77-B573-6D087947DC6FQ27307894-3D2D9FC8-4047-4AFA-9F7C-5E2E24F4D55BQ27347641-8DAEBEB3-A7C2-48BD-8EAD-E7520895DEA6Q27478313-28352C33-2990-49A0-A6CD-AD15C38571D4Q27489665-FDF83D86-A83D-4304-89D1-91E277162DA2Q28274712-450AD2BD-C6D4-4F7D-AE77-AFFBB431E768Q30235587-F3D791D0-9CBB-44E4-A09C-A12285063EA6Q30360327-1F2E15DA-652E-4F37-ACA8-6B54A93B5F26Q33549712-7BEC6E5D-BB58-4EF5-A0F2-734FF0B7592FQ33746400-6562A573-3055-48E6-B547-D0298109B191Q33767041-11FC096C-408D-4C90-B8FB-D254E4116F8EQ33796880-2A734E44-9F75-4BEA-83D7-27A02EAECDEBQ33830715-FA72EB7A-4452-411C-82F8-4E2A78DB18C2Q33948324-7ED0D273-D5C7-4387-A308-3142925E42B8Q34127568-D55198ED-2057-40E7-A993-277DE988A9FBQ34212081-46E290F6-42B7-4885-AAAC-CFAC0BBB7E4EQ34345381-F532D298-E8E8-4D28-9686-DFA01591067CQ34378263-1B209CCC-F9BD-4105-B135-1B2472393289Q34404381-1E4C9E28-3A41-4691-98F0-0C85F0989124Q34463515-2561DC33-02A9-4DFB-8B05-9402562AB69CQ34562825-24EB5CAB-29BD-4B8C-86F1-DA0A550B5034Q34755080-1B0D1B12-736E-4E1B-9022-88F50AD86DBCQ35064319-C18EC572-86D8-4590-A0D2-0D9492DE16B3Q35142822-AEE7B1F8-9B26-478E-8FCC-0BAC254F14EEQ35195052-EB154A74-7893-400B-B1B8-DE937A2BA79EQ35235892-7FF21C83-8090-4F3E-A5E2-DAD1774068C5Q35402168-3FF7A95E-A500-4E77-93C0-354F9F04C38DQ35479221-7C9678AD-CD9F-433B-99F8-7E95B1FB7B97Q35556717-40AD0A82-2464-41FA-91BF-51F4277AFF5EQ35559692-0C047181-D493-4F47-AB6E-A76DCF2AE230Q35574951-F4F0F124-0DF1-4493-8D7F-C236CFCDC65B
P2860
Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Central role of suppressors of ...... etabolic syndrome in the mouse
@ast
Central role of suppressors of ...... etabolic syndrome in the mouse
@en
Central role of suppressors of ...... etabolic syndrome in the mouse
@nl
type
label
Central role of suppressors of ...... etabolic syndrome in the mouse
@ast
Central role of suppressors of ...... etabolic syndrome in the mouse
@en
Central role of suppressors of ...... etabolic syndrome in the mouse
@nl
prefLabel
Central role of suppressors of ...... etabolic syndrome in the mouse
@ast
Central role of suppressors of ...... etabolic syndrome in the mouse
@en
Central role of suppressors of ...... etabolic syndrome in the mouse
@nl
P2860
P3181
P356
P1476
Central role of suppressors of ...... etabolic syndrome in the mouse
@en
P2093
Tatsuya Kondo
Yu-Hua Tseng
P2860
P304
P3181
P356
10.1073/PNAS.0402511101
P407
P577
2004-07-13T00:00:00Z